Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

ClinicalTrials.gov ID: NCT02864953

Public ClinicalTrials.gov record NCT02864953. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of Part 1 of the study is to determine if BIIB093 improves functional outcome at Day 90 as measured by the modified Rankin Scale (mRS) when compared with placebo in participants with Large Hemispheric Infarction (LHI). The secondary objectives of Part 1 of the study are to determine if BIIB093 improves overall survival at Day 90 when compared with placebo, if BIIB093 improves functional outcome at Day 90 on the mRS dichotomized 0-4 vs. 5-6 when compared with placebo, if BIIB093 reduces midline shift at 72 hours (or at time of decompressive craniectomy \[DC\] or comfort measures only \[CMO\], if earlier) when compared with placebo, and to evaluate the safety and tolerability of BIIB093 in participants with LHI. The objectives of Part 2 of the study are to evaluate long-term disability following LHI, to evaluate long-term outcome measures of clinical function, quality of life, and healthcare utilization, and to assess the safety of BIIB093 in subjects with LHI during the follow-up period.

Study identification

NCT ID
NCT02864953
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Remedy Pharmaceuticals, Inc.
Industry
Enrollment
535 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 29, 2018 (Actual)
Primary completion
Aug 18, 2023 (Actual)
Completion
Aug 18, 2023 (Actual)
Last update posted
Nov 25, 2024

2018 – 2023

United States locations

U.S. sites
74
U.S. states
31
U.S. cities
62
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013 —
Arizona Board of Regents, University of Arizona Tucson Arizona 85724 —
Stanford Stroke Center Palo Alto California 94304 —
University of California Davis Health System Sacramento California 95817 —
UCSD Health-La Jolla San Diego California 92121 —
University of Colorado Hospital Aurora Colorado 80045 —
Yale New Haven Hospital New Haven Connecticut 06519 —
University of Florida-Gainsville Gainesville Florida 32610 —
Lyerly Neurosurgery Baptist Health Jacksonville Florida 32207 —
University of Florida, Jacksonville Jacksonville Florida 32209 —
University of South Florida Tampa Florida 33612 —
Grady Memorial Hospital Atlanta Georgia 30303 —
Augusta University Augusta Georgia 30912 —
The Queens Medical Center Honolulu Hawaii 96813 —
Rush University Medical Center Chicago Illinois 60612 —
University of Kansas Medical Center Research Institute, Inc. Kansas City Kansas 66160 —
University of Louisville Louisville Kentucky 40202 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Maine Medical Center Portland Maine 04102 —
University of Maryland Baltimore Maryland 21201 —
Sinai Hospital of Baltimore Baltimore Maryland 21215 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Brigham and Woman's Hospital Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center, Inc. Jamaica Plain Massachusetts 02130-2075 —
UMASS Memorial Medical Center Worcester Massachusetts 01605 —
Henry Ford Hospital Detroit Michigan 48202 —
St. John's Hospital Detroit Michigan 48236 —
Fairview Southdale Hospital Edina Minnesota 55435 —
Saint Luke's Hospital of Kansas City Kansas City Missouri 64111 —
Saint Louis University St Louis Missouri 63110 —
Washington University Physicians St Louis Missouri 63110 —
JFK Medical Center Edison New Jersey 08820 —
Jersey Shore University Medical Center Neptune City New Jersey 07753 —
Rutgers - Robert Wood Johnson Medical School New Brunswick New Jersey 08901 —
Valley Hospital Ridgewood New Jersey 07450 —
University of New Mexico Albuquerque New Mexico 87106 —
University of Buffalo Buffalo New York 14215 —
Northwell Health Manhasset New York 11030 —
NYU Langone Medical Center New York New York 10016 —
Mount Sinai Hospital New York New York 10029 —
Columbia University Hervert Irving Comprehensive Cancer Center New York New York 10032 —
University of Rochester Medical Center Rochester New York 14642 —
SUNY Upstate Medical Center Syracuse New York 13210 —
UNC Hospitals Chapel Hill North Carolina 27514 —
Atrium Health Carolinas Medical Center Charlotte North Carolina 28204 —
Duke University Medical Center Durham North Carolina 27710 —
Guilford Neurologic Research, PA Greensboro North Carolina 27405 —
Novant Health Forsyth Medical Center Winston-Salem North Carolina 27103 —
Wake Forest Baptist Health Sciences Winston-Salem North Carolina 27157 —
Summa Health System Akron Ohio 44304 —
University of Cincinnati Cincinnati Ohio 45267 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
Ohio State Univ College Of Medicine Columbus Ohio 43210 —
Miami Valley Hospital South Dayton Ohio 45409 —
ProMedica Toledo Hospital Toledo Ohio 43606 —
Ascension St. John Tulsa Oklahoma 74104 —
Providence Brain and Spine Institute Portland Oregon 97225 —
Oregon Health & Science University Portland Oregon 97239 —
Lehigh Valley Hospital - Cedar Crest Allentown Pennsylvania 18103 —
Penn State University Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
University of Pennsylvania Health System Philadelphia Pennsylvania 19104 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
University of Pittsburgh School of Medicine Pittsburgh Pennsylvania 15261 —
Rhode Island Hospital Warren Alpert Medical School Brown University Providence Rhode Island 02905 —
Erlanger Health System Chattanooga Tennessee 37403 —
University of Tennessee Health Sciences Center Memphis Tennessee 38163 —
TriStar Skyline Medical Center Nashville Tennessee 37207 —
Vanderbilt Medical Center Nashville Tennessee 37232 —
St.David's HealthCare Office of Research Austin Texas 78705 —
Valley Baptist Medical Center Harlingen Texas 78550 —
University of Utah Neurology Salt Lake City Utah 84108 —
University of Washington School of Medicine Seattle Washington 98195 —
University Hospital and UW Health Clinics Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 176 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02864953, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 25, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02864953 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →